The Patient-Centered Future of Clinical Trials

As the COVID-19 pandemic spread, regulatory agencies became more flexible, opening the door for decentralized and technology-enabled clinical trials. Join our panelists to learn more about this regulatory shift and how these changes may enable more patient-centric models in the future for rare disease research. We will be discussing the expanded use of remote monitoring technologies and remote data capture as well as how to advance endpoint design and measurement through collaboration with patients and advocates.

In this discussion you will learn about:
– Decentralized trials and how they can be more patient-centric than traditional clinical trials
– The accelerated adoption and use of telehealth, home administration and remote monitoring due to the COVID-19 global pandemic
– Creating a more patient-inclusive clinical paradigm using these trial models

Meet your speakers for this session:

• Julia Anthony
• Scott Schliebner
• Isaac Rodrigues-Chavez
• Zachary Hallinan